ClinConnect ClinConnect Logo
Search / Trial NCT06008834

First-day Discharge Enhanced Recovery After Surgery Protocol for Minimal Invasive Colorectal Surgery

Launched by CORPORACION PARC TAULI · Aug 23, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a special approach called the Enhanced Recovery After Surgery (ERAS) protocol for patients undergoing minimally invasive surgeries for colorectal disorders, specifically right colectomy or sigmoidectomy. The goal is to see if patients can safely go home just one day after surgery while still receiving support from healthcare professionals at home. The hope is that this method can help patients recover faster and reduce the chances of needing to return to the hospital after their surgery.

To participate in this trial, patients need to be between the ages of 65 and 74 and meet certain criteria, such as having a planned minimally invasive surgery for a non-emergency condition, and having family support to assist them at home. Patients who have had certain health issues or treatments, like recent chemotherapy or specific blood conditions, are not eligible. If you join the study, you can expect to follow a set recovery plan and have regular check-ins from healthcare providers after you leave the hospital, helping to ensure a smooth recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pacients who undergo a minimal invasive sigmoidectomy or right colectomy.
  • Benign or malignant desease.
  • No expected stoma
  • ASA ≤ III
  • Family support
  • Exclusion Criteria:
  • Emergency surgery
  • Anticoagulant therapy
  • Recent immunosupresor therapy (less than one month)
  • Anemia (Male Hb \>120 g/L, Female Hb \>110 g/L)
  • Malnutrition (Albumine \>35 g/L)
  • Dementia
  • Moderate or high frailty
  • Syncronic neoplasia
  • Previous colorectal surgery

About Corporacion Parc Tauli

Corporación Parc Taulí is a leading healthcare organization based in Sabadell, Spain, known for its commitment to advancing medical research and clinical excellence. With a focus on innovative healthcare solutions, the organization integrates cutting-edge technology and multidisciplinary collaboration to enhance patient outcomes. As a sponsor of clinical trials, Corporación Parc Taulí emphasizes ethical practices, rigorous scientific methodologies, and robust data management to contribute to the development of new therapies and improve healthcare standards. Their dedication to research and patient care positions them as a vital player in the clinical research landscape.

Locations

Sabadell, Barcelona, Spain

Patients applied

0 patients applied

Trial Officials

Anna Pallisera-Lloveras, MD, PhD

Principal Investigator

Corporacio Parc Tauli. Parc Tauli University Hospital

Laura Mora-Lopez, MD, PhD

Study Director

Corporacio Parc Tauli. Parc Tauli University Hospital

Oriol Pino-Perez, MD

Principal Investigator

Corporacio Parc Tauli. Parc Tauli University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported